For 21 years under the provisions of DSHEA, the FDA has had primary responsibility for ensuring that appropriate regulatory actions are taken against marketed products that present significant health risks or bear false or misleading label claims. Foundational to the evaluation of such risks and claims is an adequate scientific base for decision-making. For botanical dietary ingredients, development of such a science base is wide-ranging because of several unique features, including the variability of sourcing, lack of manufacturing controls, complexity of the constituents, lack of availability of reference materials widespread usage in the marketplace and unknown adverse effects due to herb-herb, or herb-drug interactions. In 2010 the FDA fully implemented the current good manufacturing practices (cGMP) for the botanical dietary supplement industry placing the onus of ?botanical identity and authenticity? on the manufacturers of dietary supplements containing various botanical ingredients. However, these cGMP's have highlighted the ambiguity of exactly what constitutes a ?scientifically valid method? for the determination of the identity authenticity and safety of botanical materials. To address these complex issues surrounding botanical identity, authenticity, and safety and in continuation of our cooperative agreement with the FDA, the NCNPR has established the following specific aims to aid in the research needs of the FDA: 1) Assist in the identification and development of a list of dietary herbal supplements and botanical ingredients, based on safety concerns, trends, and knowledge of botanicals being marketed in the U.S., to prioritize for further research. 2) Acquire, validate, and characterize authenticated reference materials, including raw and processed plant materials and purified natural products of relevance to FDA, for the assessment of their fingerprinting, adulteration, safety and toxicity. 3) Exchange technical and scientific information, analytical methods, and reference material with FDA scientists and other stakeholders. 4) Collaborate with FDA scientists in research areas of mutual interest. 5) Coordinate scientific workshops and conferences on BDS-related topics of

Public Health Relevance

This project supports a research program on the quality and safety of botanical ingredients used in the United States. The study results provide information to support regulatory decisions by the US Food and Drug Administration regarding these products. The investigators will obtain authentic plants and reference materials, develop measurement and identification techniques for the active or toxic principles, and provide these tools to the FDA, Industry, Trade Associations, and other stakeholders.

National Institute of Health (NIH)
Food and Drug Administration (FDA)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Mississippi
Organized Research Units
United States
Zip Code
Manda, Vamshi K; Avula, Bharathi; Ashfaq, Mohammad K et al. (2017) Quantification of mesembrine and mesembrenone in mouse plasma using UHPLC-QToF-MS: Application to a pharmacokinetic study. Biomed Chromatogr 31:
Parveen, Iffat; Gafner, Stefan; Techen, Natascha et al. (2016) DNA Barcoding for the Identification of Botanicals in Herbal Medicine and Dietary Supplements: Strengths and Limitations. Planta Med 82:1225-35
Chittiboyina, Amar G; Avonto, Cristina; Khan, Ikhlas A (2016) What Happens after Activation of Ascaridole? Reactive Compounds and Their Implications for Skin Sensitization. Chem Res Toxicol 29:1488-92
Wang, Mei; Carrell, Emily J; Chittiboyina, Amar G et al. (2016) Concurrent supercritical fluid chromatographic analysis of terpene lactones and ginkgolic acids in Ginkgo biloba extracts and dietary supplements. Anal Bioanal Chem 408:4649-60
Carpenter, Jessica M; Jourdan, Mary K; Fountain, Emily M et al. (2016) The effects of Sceletium tortuosum (L.) N.E. Br. extract fraction in the chick anxiety-depression model. J Ethnopharmacol 193:329-332
Sagi, Satyanarayanaraju; Avula, Bharathi; Wang, Yan-Hong et al. (2016) Quantification and characterization of alkaloids from roots of Rauwolfia serpentina using ultra-high performance liquid chromatography-photo diode array-mass spectrometry. Anal Bioanal Chem 408:177-90
Avonto, Cristina; Chittiboyina, Amar G; Wang, Mei et al. (2016) In Chemico Evaluation of Tea Tree Essential Oils as Skin Sensitizers: Impact of the Chemical Composition on Aging and Generation of Reactive Species. Chem Res Toxicol 29:1108-17
Manda, Vamshi K; Avula, Bharathi; Chittiboyina, Amar G et al. (2016) Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. Xenobiotica 46:117-25
Avonto, C; Wang, Y-H; Avula, B et al. (2016) Comparative studies on the chemical and enzymatic stability of alpha- and beta-arbutin. Int J Cosmet Sci 38:187-93
Carpenter, Jessica M; Criddle, Catherine A; Craig, Helaina K et al. (2016) Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats. Fitoterapia 109:87-90

Showing the most recent 10 out of 58 publications